After Disappointing Earnings, Is Danaher Corporation Still Worth Investing In?
Danaher Corporation's (NYSE: DHR) second-quarter results were almost an investing trivia question: Which company beat earnings expectations and raised full-year guidance, but still managed to disappoint investors? The answer: Danaher. Its earnings were good, but the company is tracking behind its full-year revenue guidance, and there are question marks on its dental segment. Is Danaher still worth investing in?
Management's guidance going into the second-quarter was for core revenue growth of around 2.5% and adjusted diluted non-GAAP EPS in the range of $0.95 to $0.98. The good news is that adjusted diluted noon-GAAP EPS came in $0.99 in the quarter and management subsequently raised its full-year adjusted diluted non-GAAP EPS guidance range to $3.90-$3.97 from $3.85-$3.95.
Weakness in dental consumables has hurt Danaher Corporation. Image source: Danaher Corporation.
Source: Fool.com
3M Company Stock
The sentiment is rather negative at the moment with 9 Sell predictions and 2 Buy predictions.
A slightly negative potential of -9.94% at a current price of 88.83 € for 3M Company is the result of a target price of 80 €.
